Updated:
Alwyn Capital
Partnering with early-stage biotech innovators to transform trillion-dollar industries and build a brighter future. | The firm backs pre-Seed and Seed stage...
Overview
Partnering with early-stage biotech innovators to transform trillion-dollar industries and build a brighter future. | The firm backs pre-Seed and Seed stage biotechnology breakthroughs across protein innovation, next-generation materials, and advanced biological modeling that are redefining trillion-dollar legacy industries to create a more equitable and sustainable future.
General information
Firm type
Generalist
Year founded
2018
Location
Region
North America
Country
United States
City
Brooklyn
Corporate office
Brooklyn, United States
Principals
David Magerman
Founder
Heather Courtney
Founder / CEO
Sector focus
Frequently asked questions
Who runs investment decisions at Alwyn Capital?
Heather Courtney serves as founding general partner and CEO. David Magerman supplies the primary capital as founder.
What investment stages does Alwyn Capital typically target?
The firm targets early-stage opportunities.
How is Alwyn Capital related to GlassWall Syndicate?
Heather Courtney serves as a deal lead for the GlassWall Syndicate impact investment network.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: